Medexus Pharmaceuticals Inc
TSX:MDP
Income Statement
Earnings Waterfall
Medexus Pharmaceuticals Inc
Revenue
|
115.7m
USD
|
Cost of Revenue
|
-54.5m
USD
|
Gross Profit
|
61.2m
USD
|
Operating Expenses
|
-48.4m
USD
|
Operating Income
|
12.8m
USD
|
Other Expenses
|
-6.9m
USD
|
Net Income
|
5.9m
USD
|
Income Statement
Medexus Pharmaceuticals Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
4
N/A
|
5
+17%
|
4
-17%
|
4
-4%
|
3
-10%
|
3
-8%
|
3
-9%
|
3
+19%
|
4
+5%
|
4
+7%
|
4
+7%
|
4
+10%
|
5
+17%
|
6
+20%
|
8
+25%
|
9
+15%
|
10
+7%
|
10
+5%
|
11
+8%
|
11
+3%
|
23
+108%
|
34
+46%
|
47
+38%
|
60
+28%
|
61
+3%
|
74
+21%
|
86
+15%
|
93
+8%
|
108
+16%
|
80
-26%
|
69
-13%
|
64
-8%
|
53
-16%
|
77
+44%
|
82
+8%
|
92
+12%
|
100
+8%
|
108
+8%
|
117
+8%
|
119
+2%
|
116
-3%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
(0)
|
(1)
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(6)
|
(10)
|
(14)
|
(19)
|
(24)
|
(26)
|
(33)
|
(39)
|
(43)
|
(51)
|
(38)
|
(35)
|
(33)
|
(28)
|
(39)
|
(39)
|
(42)
|
(45)
|
(48)
|
(52)
|
(55)
|
(54)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
2
+258%
|
0
N/A
|
2
N/A
|
2
+6%
|
2
+35%
|
3
+9%
|
3
+11%
|
3
+7%
|
3
+9%
|
4
+20%
|
5
+12%
|
5
+6%
|
5
+3%
|
6
+9%
|
6
+3%
|
13
+138%
|
20
+49%
|
28
+41%
|
36
+27%
|
36
+0%
|
42
+16%
|
47
+12%
|
50
+7%
|
58
+15%
|
42
-27%
|
34
-19%
|
31
-10%
|
26
-16%
|
38
+48%
|
44
+16%
|
51
+15%
|
55
+9%
|
60
+9%
|
64
+7%
|
64
+0%
|
61
-5%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(5)
|
(7)
|
(6)
|
(7)
|
(7)
|
(7)
|
(8)
|
(7)
|
(8)
|
(4)
|
(1)
|
(1)
|
(1)
|
(4)
|
(7)
|
(7)
|
(8)
|
(8)
|
(8)
|
(8)
|
(14)
|
(21)
|
(30)
|
(39)
|
(43)
|
(46)
|
(52)
|
(53)
|
(51)
|
(42)
|
(44)
|
(46)
|
(44)
|
(50)
|
(50)
|
(50)
|
(51)
|
(52)
|
(52)
|
(50)
|
(48)
|
|
Selling, General & Administrative |
(4)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(8)
|
(8)
|
(8)
|
(8)
|
(14)
|
(21)
|
(29)
|
(38)
|
(40)
|
(41)
|
(42)
|
(42)
|
(45)
|
(36)
|
(37)
|
(37)
|
(36)
|
(44)
|
(44)
|
(46)
|
(47)
|
(48)
|
(48)
|
(47)
|
(46)
|
|
Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(7)
|
(6)
|
(6)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Other Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
3
|
6
|
6
|
6
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(7)
|
(7)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
0
|
0
|
(0)
|
(1)
|
0
|
0
|
0
|
0
|
|
Operating Income |
(1)
N/A
|
(2)
-223%
|
(2)
-6%
|
(3)
-54%
|
(4)
-31%
|
(5)
-19%
|
(6)
-11%
|
(5)
+8%
|
(5)
+1%
|
(1)
+75%
|
2
N/A
|
2
+9%
|
2
+15%
|
(1)
N/A
|
(3)
-302%
|
(3)
+16%
|
(3)
+3%
|
(3)
-4%
|
(2)
+15%
|
(2)
+18%
|
(0)
+84%
|
(1)
-181%
|
(2)
-78%
|
(3)
-103%
|
(7)
-125%
|
(4)
+46%
|
(5)
-25%
|
(3)
+39%
|
6
N/A
|
(0)
N/A
|
(10)
-3 277%
|
(16)
-55%
|
(18)
-15%
|
(12)
+31%
|
(6)
+52%
|
1
N/A
|
4
+280%
|
8
+95%
|
13
+49%
|
14
+12%
|
13
-9%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
0
|
(1)
|
2
|
4
|
0
|
(5)
|
(10)
|
(29)
|
(30)
|
(24)
|
(8)
|
10
|
11
|
9
|
(8)
|
(11)
|
(13)
|
(15)
|
(15)
|
(14)
|
|
Non-Reccuring Items |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(5)
|
(5)
|
(5)
|
(1)
|
(1)
|
(4)
|
0
|
0
|
(4)
|
(1)
|
0
|
0
|
(0)
|
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
Total Other Income |
(2)
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(3)
N/A
|
(4)
-63%
|
(4)
-3%
|
(5)
-26%
|
(5)
+11%
|
(5)
-7%
|
(6)
-16%
|
(6)
+4%
|
(6)
-3%
|
(2)
+60%
|
1
N/A
|
1
+15%
|
1
+28%
|
(2)
N/A
|
(4)
-140%
|
(4)
+11%
|
(4)
+1%
|
(3)
+10%
|
(3)
+12%
|
(6)
-107%
|
(7)
-5%
|
(6)
+5%
|
(8)
-22%
|
(3)
+57%
|
(5)
-39%
|
(7)
-60%
|
(10)
-31%
|
(13)
-33%
|
(27)
-109%
|
(32)
-18%
|
(34)
-7%
|
(24)
+30%
|
(8)
+65%
|
(4)
+54%
|
1
N/A
|
(9)
N/A
|
(9)
+3%
|
(5)
+42%
|
(3)
+48%
|
(1)
+60%
|
(1)
+16%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
1
|
1
|
1
|
3
|
4
|
6
|
6
|
1
|
1
|
(2)
|
(2)
|
6
|
6
|
6
|
7
|
|
Income from Continuing Operations |
(3)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(2)
|
1
|
1
|
1
|
(2)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(6)
|
(7)
|
(7)
|
(8)
|
(4)
|
(5)
|
(6)
|
(9)
|
(12)
|
(26)
|
(28)
|
(30)
|
(18)
|
(2)
|
(3)
|
2
|
(11)
|
(11)
|
1
|
3
|
5
|
6
|
|
Net Income (Common) |
(3)
N/A
|
(4)
-63%
|
(4)
-3%
|
(5)
-26%
|
(5)
+11%
|
(5)
-7%
|
(6)
-16%
|
(6)
+4%
|
(6)
-3%
|
(2)
+60%
|
1
N/A
|
1
+15%
|
1
+28%
|
(2)
N/A
|
(4)
-140%
|
(4)
+11%
|
(4)
+1%
|
(3)
+10%
|
(3)
+12%
|
(6)
-107%
|
(7)
-5%
|
(7)
+2%
|
(8)
-23%
|
(4)
+54%
|
(5)
-35%
|
(6)
-25%
|
(9)
-42%
|
(12)
-30%
|
(26)
-125%
|
(28)
-9%
|
(30)
-7%
|
(18)
+40%
|
(2)
+89%
|
(3)
-44%
|
2
N/A
|
(11)
N/A
|
(11)
-3%
|
1
N/A
|
3
+168%
|
5
+50%
|
6
+20%
|
|
EPS (Diluted) |
-1.81
N/A
|
-2.58
-43%
|
-0.87
+66%
|
-1.08
-24%
|
-0.97
+10%
|
-1.04
-7%
|
-1.2
-15%
|
-1.15
+4%
|
-1.19
-3%
|
-0.48
+60%
|
0.15
N/A
|
0.18
+20%
|
0.23
+28%
|
-0.38
N/A
|
-0.83
-118%
|
-0.66
+20%
|
-0.66
N/A
|
-0.61
+8%
|
-0.53
+13%
|
-1.09
-106%
|
-0.5
+54%
|
-0.66
-32%
|
-0.54
+18%
|
-0.26
+52%
|
-0.35
-35%
|
-0.43
-23%
|
-0.62
-44%
|
-0.81
-31%
|
-1.8
-122%
|
-1.86
-3%
|
-1.57
+16%
|
-0.93
+41%
|
-0.08
+91%
|
-0.15
-88%
|
0.13
N/A
|
-0.53
N/A
|
-0.55
-4%
|
0.06
N/A
|
0.16
+167%
|
0.24
+50%
|
0.24
N/A
|